Exchanges At Goldman Sachs
The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:26:30
- Mas informaciones
Informações:
Sinopsis
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.
